Research Article (Open access) |
---|
ABSTRACT- Medicinal plants contain valuable sources of biological components that are helpful in control and cure of
ageing diseases. Protein component present in various parts of the medicinal plants is the rich sources of medicine that
contains a permanent cure for several diseases. The studies on edible sources like C. lanatus testa (or seed coat) are to be
conducted to understand, the better action against human diseases. The purified inhibitor is separated by SDS PAGE and
analyzed by MS-MASCOT shown sequence as “MQDVKTYPPAAPVPATPRFGSLAG SLIEINR”. The C. lanatus testa
crude extracts were revealed good antifungal activity against A. niger (18mm) and C. albicans (13mm). The C. lanatus
testa purified extracts were revealed good antifungal activity against A. niger (21 mm) and C. albicans (20mm).
Fluconazole was used as a fungal standard, shown inhibition zone for A. niger (14mm) and C. albicans (20mm). The C.
lanatus Trypsin Inhibitor (CLTI) extracts from testa at 100µg/ml were shown good activity with A. niger acting as
antifungal agent compared to standard antibiotic (Fluconazole). The C. lanatus testa Trypsin inhibitor, it is also shown
good results for anti-proliferative activity. The results were shown good antiproliferation activity with MCF-7 (Breast
Cancer) cell line due to gradual decrease in the percentage of cell survival. The IC50 for standard drug (Tamoxifen) with
MCF-7 (Breast Cancer) cell line was shown as 12µg/ml. The IC50 of CLTI peptide was shown as 60µg/ml and crude as
190µg/ml. The IC50 for standard drug (Tamoxifen) with Hep-G2 (Liver Cancer) Cell line is shown as11 µg/ml. The IC50 of
CLTI peptide with Hep-G2 (Liver Cancer) Cell line was shown as 41 µg/ml and C. lanatus testa crude extract as 144
µg/ml. The experimentation concludes that serine protease inhibitors present in testa of C.lanatus shown both antifungal
and antiproliferative properties.
Key Words- C. lanatus testa, Trypsin inhibitor, Antifungal activity, Antiproliferative activity, Breast and liver cell lines
INTRODUCTION
Most of the prominent experts have compiled comprehensive
and survey of research in science and allied disciplines
[1]. Analyses of the challenges are performing through high
quality science research as a main context of the broader
information systems community [2]. An advance in
genetics, biotechnology, phytochemistry and engineering
involves research leading to new manufacturing concepts
for the production of medicinal compounds that can lead to
a new manufacturing model [3].
Several governments have focused on medicinal plants that
provide more sustain study in the subject of drug
production [4]. The medicinal plant, C. lanatus belongs to
Cucurbitaceae family is using as fruit and vegetable from
the past decades. The fruits and seeds of this plant are
helpful in the control of aging diseases like diabetes and
cancer. One of the prerequisites in the primary health care
is the availability in the use of sustainable drugs from
plants that have a common source of medicaments. The
plants form traditional preparations are pure, active
principles from extracts that have actions or uses in therapy
[5]. Traditional plants medicines are used throughout the
world that clean only depicts that are important in health
and economy [6].
The inhibition of proteinase by protease inhibitor is an
example of protein-protein interaction, where the special
features of tie binding of two partners form complex
structures [7]. A characterization of Helicover paarmigera
contains proteinases and the interaction with proteinase
inhibitors using x-ray film contact print technique has been
experimented basis on basic method [8].
Enzyme inhibitors combine with enzymes to covalently
make them inactivate irreversibly. The irreversible inhibitors
are toxic substances and they may be natural or synthetic.
Serine proteases like trypsin can be assayed for its
activity in the presence of appropriate irreversible inhibitors
to study their inhibitory effects of an enzyme activity.
Enzyme activity is influenced by metal ions. The activity
depends on the nature of various amino acid residues
present at the active site of the enzyme. The effect of
several metal ions can be studied by examining the enzyme
activity in the presence of metal containing salts.
Plants have well-established class of inhibitors called
Serine protease inhibitors that show resistance against
microorganisms. Protease inhibitors will able to disruption
cell damage and enhance the cell's life-span [9]. Plants
produce various peptides and proteins that are extracted and
purified which act as antimicrobials [10]. A novel method
can be used for development of novel antimicrobial agents.
Homologous inhibitor show molecular modelling and
dynamics studies that are measured with Escherichia coli
trypsin and chymotrypsin proteins. The interactions are
provided based on inhibitor–enzyme docking studies [11].
Protease inhibitors ALLN and ALLM are of calpain and
cathepsin proteases inhibitor that shows antiproliferative
activity [12]. The action of Bowman-Birk protease inhibitor
from leguminous family was shown antitumor and
antiproliferative properties [13]. Aprotinin, pepstatin, and
soybean trypsin inhibitor exhibit anticancer properties [14].
L. acutangula (var) Amara annual herb is belonging to the
family, Cucurbitaceae contains ribosome-inactivating
proteins, monocotyledon mannose-binding lectins,
amaranthins and Cucurbitaceae phloem lectins act as
antiproliferative activity [15]. Calf serum (FCS), Dulbecco's
Modified Eagle medium (DMEM), paclitaxel (PTX),
EDTA, trypsin, penicillin, amphotericin exhibit a powerful
antiproliferation [16]. Protein inhibitors of trypsin from the
seeds of cucurbitaceae plants have shown a good antiproliferative
activity [17].
MATERIALS AND METHODS
Collection of C. Lanatus fruits:
In the present experiment, Citrullus lanatus fruits were
collected from the fields of Visakhapatnam district, AP,
India during March to June 2011. The plants are authenticated
by Dr. P.V. Arjun Rao, Ethanobotanist, Dept. of
Botany, Phytopharma Technology Laboratory, Visakhapatnam
(No. Res/2 dated 21-09-2010). Citrullus lanatus., on
comparison with the details given in “FLORA OF THE
PRESIDENCY OF MADRAS” by J.S. Gamble, Volume i,
Page nos.534-536, Bishen Singh Mahendra Pal Singh publishers,
India (2004) and “Flowering plants from Chittoor
district, Andhra Pradesh, India” by K. Madhava Chetty, K.
Sivaji and K. TulasiRao, First edition published by students
offset printers, Thirupathi, India, pp. 137-139 (2008).
Preparation of Crude Extract:
The seeds present in the fruits are collected and dried for
two days. The testa is separated and crushed to a fine
powder using motar and pestle. The fine testa powder is
selected for the present experimentation.
The testa powder was depigmented, dehydrated, and defatted
by washing with acetone for several times, followed by
hexane and Folch’s mixture (chloroform: methanol, 2:1)
and with 1% PVP. The solvents were removed by filtration
and the powder air-dried. Testa powder was homogenized
in 100 ml of 0.1M phosphate buffer pH 7.0 and the extract
was prepared in 500 ml conical flask. The homogenate was
mixed by incubating the extract in a rotary shaker at 120
rpm for 30 minutes at room temperature. Then the cell debris
was removed by the slurry filtered through cheesecloth.
The filtrate was collected and centrifuged at 10,000
rpm for 15 minutes at 4°C [18]. The crude extract appears
as a clear supernatant was selected for further precipitation
of inhibitor by Ammonium sulphate precipitation.
Ammonium sulphate precipitation and dialysis:
Citrullus lanatus testa protein was precipitated by the
Ammonium sulfate precipitation method. The protein
isolation was done based on the method done by Englard
and Seifter, 1990 [19]. The unwanted proteins are removed
by ammonium sulphate precipitation and at the same time
the protein of interest could be concentrated. Varying
concentrations of ammonium sulphate (30%, 50%, 70%
and 90%) to the crude extract was kept at 4°C for about one
day precipitation to optimize the selected protease inhibitor.
The precipitated protease inhibitor was collected by centrifugation
of extract at 10,000 rpm at 4°C for 15 minutes.
The precipitated protein was further dialyzed against 0.01M
phosphate buffer (pH 7.0) to remove the ammonium
sulphate present in the precipitate as details given below.
The dialysis tube (Sigma-Aldrich) was washed in running
water for about 3-4 hrs. The tube was rinsed with the 0.3%
(w/v) solution sodium sulfide at 80°C for 1 minute. After
washing with hot water (60°C) for 2 minutes, the solution
was acidified with 0.2% sulphuric acid (v /v) and rinsed
with hot water (60°C).The process is done to build the
pores of the tube more clear. Tube will be opened, then
pack the sample solution and this packed solution was keep
in 0.01M phosphate buffer. This method has helped to
removal of salts in the sample solution. Finally the protein
was lyophilized and subjected to various analytical
techniques and also used in the further purification.
Purification of Trypsin Inhibitor
Ion Exchange Chromatography:
The active protease inhibitor fraction that was attained after
the process of dialysis by ammonium sulphate precipitation
was purified by Ion exchange chromatography using an
anion exchanger called DEAE cellulose. Proteins obtained
due to surface charge will bind to ion exchangers. The
reversibly adsorbed proteins were eluted out by using either
through a salt gradient or pH.
Activation of DEAE Cellulose:
The DEAE cellulose 10g was soaked in double distilled
water, allowed to settle, and the fine particle was removed
by decanting. It was then suspended in 0.1M HCl for
overnight. Remove the hydrochloric acid and wash with
double distilled water, then add 0.1M NaOH incubate for
overnight. Decanted the sodium hydroxide solution and
washed several times with distilled water in a sintered glass
funnel using vacuum filtration, until the pH of the washings
became neutral. Equilibration of the resin in appropriate
buffer by repeated washings with the same buffer was
conducted.
Purification Using DEAE Cellulose Column:
DEAE cellulose activated as carefully packed up
(1.5X30cm) column and was equilibrated with phosphate
buffer pH 7.0. A protein content of 4.1mg/ml from 30 ml of
the dialyzed sample was used in the pre-equilibrated DEAE
cellulose column. The complete addition of sample into
pre-equilibrated DEAE cellulose column was connected to
the reservoir that contains the phosphate buffer that
adjusted with a flow rate of 2 ml per minute.
The unbound proteins obtained were washed out until
absorbance reached near to zero at 280 nm. An elution was
completed at a flow rate of 2ml per minute using gradients
stepwise with sodium chloride that ranges from 0.1 to 0.5M
that was prepared in 0.01M phosphate buffer at 7.0 pH.
About 2 ml of fractions from columns were collected and
the protein content of each fraction was being estimated by
measuring the OD at 280 nm. The peak fractions from the
column were then pooled and were again dialyzed against
the 0.01M phosphate buffer at pH 7.0. The dialyzed fractions
from testa of C. lanatus were assayed for protease
inhibitory activity, protein content and specific activity.
Gel Filtration on Sephadex G -50:
Sephadex G-50 activated as carefully packed up (1.5X50
cm) column without any air bubble and the column was
equilibrated with 0.1M phosphate buffer pH 7.0. The
samples were dissolved in 0.1M phosphate buffer pH 7.0,
that samples were loaded on sephadex G-50 column. The
column was previously equilibrated with 0.1M phosphate
buffer pH7.0 and the sample was eluted in the same buffer
with a flow rate of 2 ml/minute, 2 ml fractions were
collected at a flow rate of 120ml per hour and protein
absorbance was measured at 280 nm.
Calculation of yield of protein or protease inhibitor activity
of each fraction during purification is the percent activity
obtained by dividing the total protein content or activity of
that fraction with the total protein content or activity of the
crude extract. Fold of purification in each step was
calculated by dividing the specific activity of the respective
fraction with that of the crude extract.
Fungi | ||||||
DMS O (Control) |
Fluconazole (Standard) | |||||
10µg/ ml | 25µg /ml | 50µg /ml | 100µg /ml | |||
Candida albicans | - | - | 10 | 13 | - | 20 |
Aspergillus niger | 11 | 12 | 14 | 18 | - | 14 |
Fungi | ||||||
C. lanatus purified testa extract | DMS
O (Control) |
Fluconazole (Standard) | ||||
10µg/ ml | 25µg/ ml | 50µg/ ml | 100µ g/ml | |||
Candida albicans |
- | - | 18 | 20 | -- | 20 |
Aspergillus niger |
- | 12 | 20 | 21 | -- | 14 |
Conc. (in µg /ml) | ||||||
% of Cell survival | % of Cell inhibition | % of cell survival | % of cell inhibition | % of cell survival | % of cell inhibition | |
6.25 | 82.3 | 17.7 | 97.8 | 2.2 | 93.5 | 6.5 |
12.5 | 45.5 | 54.5 | 84.1 | 15.9 | 89.5 | 10.5 |
50 | 30.9 | 69.1 | 76.7 | 23.3 | 56.4 | 43.6 |
100 | 16 | 84 | 58.5 | 41.5 | 32.3 | 67.7 |
200 | 4.9 | 95.1 | 49 | 51 | 21.2 | 78.8 |
250 | 0.4 | 99.6 | 30 | 70 | 13.4 | 86.6 |
Conc. (in µg /ml) | ||||||
% of cell survival | % of cell inhibition | % of cell survival | % of cell inhibition | % of cell survival | % of cell inhibition | |
6.25 | 82.3 | 17.7 | 94 | 6 | 89.7 | 10.3 |
12.5 | 45.5 | 54.5 | 87.9 | 12.1 | 65.8 | 34.2 |
50 | 37.4 | 62.6 | 70.1 | 29.9 | 45.5 | 54.5 |
100 | 29.2 | 70.8 | 58.4 | 41.6 | 38.6 | 61.4 |
200 | 21 | 79 | 39.7 | 60.3 | 31.5 | 68.5 |
250 | 11.2 | 88.8 | 22.2 | 77.8 | 13.6 | 86.4 |
International Journal of Life-Sciences Scientific Research (IJLSSR)
Open Access Policy
Authors/Contributors are responsible for originality, contents, correct
references, and ethical issues.
IJLSSR publishes all articles under Creative Commons
Attribution- Non-Commercial 4.0 International License (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/legalcode |